Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation (Q37183578)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2009

Language	Label	Description	Also known as
English	Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation	scientific article published on March 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

1

object named as

Emmanuel Zorn

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

10

object named as

Jerome Ritz

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

object named as

Haesook Kim

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

8

object named as

Edwin P Alyea

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Robert J Soiffer

9

object named as

Robert J Soiffer

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Fabrice Porcheray

4

object named as

Fabrice Porcheray

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mehrdad Mohseni

2

object named as

Mehrdad Mohseni

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Allison Lynch

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Roberto Bellucci

6

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Christine Canning

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

publication date

1 March 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

382-388

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

CD4+CD25+ regulatory T cells and graft-versus-host disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

Modulation of graft-versus-host disease: role of regulatory T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

Regulatory T cells in immune surveillance and treatment of cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

6 September 2017

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

14 September 2017

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

14 September 2017

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

14 September 2017

IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

26 June 2018

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

3 September 2018

Association of Foxp3 regulatory gene expression with graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

3 September 2018

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2678797

3 September 2018

Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation of CD4+CD25+ regulatory T cells for clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19203731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2008.12.494

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37183578&oldid=2114076110"